Adenosine 3′:5′-cyclic monophosphate production and steroidogenesis by isolated rat adrenal glomerulosa cells. Effects of angiotensin II and [Sar1,Ala8]angiotensin II [PDF]
Robert Bing, Dennis Schulster
openalex +1 more source
Abstract Background Arterial stiffness is a crucial factor in determining an increase in systolic blood pressure and pulse pressure and can also predict the development of cardiovascular disease (CVD). The purpose of this study was to examine the relationship between arterial stiffness and future CVD.
Susan Darroudi+10 more
wiley +1 more source
Prothrombotic State and Vascular Damage in Angiotensin II-Induced Hypertension: Influence of Waterpipe Smoke Exposure. [PDF]
Beegam S+4 more
europepmc +1 more source
Electrophysiological study of the action of angiotensin II on the rat myometrium. [PDF]
G Hamon, Manuel Worcel
openalex +1 more source
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro+15 more
wiley +1 more source
The renin-angiotensin-aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II. [PDF]
Legrand M+17 more
europepmc +1 more source
pH titration effects on the cd spectra of angiotensin II, truncated peptides and other analogues: Aromatic region [PDF]
Karl Lintner+5 more
openalex +1 more source
Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo+7 more
wiley +1 more source
Validation of six commercially available angiotensin II type 1 receptor antibodies. [PDF]
Li B+5 more
europepmc +1 more source
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller+8 more
wiley +1 more source